88 related articles for article (PubMed ID: 25149066)
41. The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells.
Pink RC; Samuel P; Massa D; Caley DP; Brooks SA; Carter DR
Gynecol Oncol; 2015 Apr; 137(1):143-51. PubMed ID: 25579119
[TBL] [Abstract][Full Text] [Related]
42. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
[TBL] [Abstract][Full Text] [Related]
43. Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
Christinat Y; Krek W
Oncotarget; 2015 Apr; 6(12):10521-31. PubMed ID: 25826081
[TBL] [Abstract][Full Text] [Related]
44. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
45. MicroRNAs as potential signatures of environmental exposure or effect: a systematic review.
Vrijens K; Bollati V; Nawrot TS
Environ Health Perspect; 2015 May; 123(5):399-411. PubMed ID: 25616258
[TBL] [Abstract][Full Text] [Related]
46. L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor.
Doberstein K; Milde-Langosch K; Bretz NP; Schirmer U; Harari A; Witzel I; Ben-Arie A; Hubalek M; Müller-Holzner E; Reinold S; Zeimet AG; Altevogt P; Fogel M
BMC Cancer; 2014 Dec; 14():958. PubMed ID: 25510351
[TBL] [Abstract][Full Text] [Related]
47. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.
Yan M; Chen C; Gong W; Yin Z; Zhou L; Chaugai S; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):340-52. PubMed ID: 25504627
[TBL] [Abstract][Full Text] [Related]
48. Regulation of NF-κB signaling by oxidized glycerophospholipid and IL-1β induced miRs-21-3p and -27a-5p in human aortic endothelial cells.
Romay MC; Che N; Becker SN; Pouldar D; Hagopian R; Xiao X; Lusis AJ; Berliner JA; Civelek M
J Lipid Res; 2015 Jan; 56(1):38-50. PubMed ID: 25327529
[TBL] [Abstract][Full Text] [Related]
49. Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT.
Doberstein K; Harter PN; Haberkorn U; Bretz NP; Arnold B; Carretero R; Moldenhauer G; Mittelbronn M; Altevogt P
Int J Cancer; 2015 Mar; 136(5):E326-39. PubMed ID: 25230579
[TBL] [Abstract][Full Text] [Related]
50. miR-21 in ischemia/reperfusion injury: a double-edged sword?
Xu X; Kriegel AJ; Jiao X; Liu H; Bai X; Olson J; Liang M; Ding X
Physiol Genomics; 2014 Nov; 46(21):789-97. PubMed ID: 25159851
[TBL] [Abstract][Full Text] [Related]
51. Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis.
Prete F; Rotelli M; Stella A; Calculli G; Sgaramella LI; Amati A; Resta N; Testini M; Gurrado A
Clin Exp Med; 2023 Jul; 23(3):607-617. PubMed ID: 35913675
[TBL] [Abstract][Full Text] [Related]
52. Exosomes on Endometrial Cancer: A Biomarkers Treasure Trove?
Sykaras AG; Christofidis K; Politi E; Theocharis S
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406505
[TBL] [Abstract][Full Text] [Related]
53. Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.
Amirfallah A; Knutsdottir H; Arason A; Hilmarsdottir B; Johannsson OT; Agnarsson BA; Barkardottir RB; Reynisdottir I
PLoS One; 2021; 16(11):e0260327. PubMed ID: 34797887
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Qiu K; Song Y; Rao Y; Liu Q; Cheng D; Pang W; Ren J; Zhao Y
Front Oncol; 2021; 11():711171. PubMed ID: 34646767
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-21: An Emerging Player in Bone Diseases.
Chen C; Liu YM; Fu BL; Xu LL; Wang B
Front Pharmacol; 2021; 12():722804. PubMed ID: 34557095
[TBL] [Abstract][Full Text] [Related]
56. Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets.
Dräger O; Metz K; Busch M; Dünker N
Mol Oncol; 2022 Feb; 16(4):957-981. PubMed ID: 34228897
[TBL] [Abstract][Full Text] [Related]
57. LINC00461 Promoted Endometrial Carcinoma Growth and Migration by Targeting MicroRNA-219-5p/Cyclooxygenase-2 Signaling Axis.
Wang Y; Yin L
Cell Transplant; 2021; 30():963689721989616. PubMed ID: 33573388
[TBL] [Abstract][Full Text] [Related]
58. Endometrial Cancer Cells Promote M2-Like Macrophage Polarization by Delivering Exosomal miRNA-21 under Hypoxia Condition.
Xiao L; He Y; Peng F; Yang J; Yuan C
J Immunol Res; 2020; 2020():9731049. PubMed ID: 33110923
[TBL] [Abstract][Full Text] [Related]
59. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
Kanchan RK; Siddiqui JA; Mahapatra S; Batra SK; Nasser MW
Mol Cancer; 2020 Feb; 19(1):29. PubMed ID: 32059676
[TBL] [Abstract][Full Text] [Related]
60. Three-microRNA expression signature predicts survival in triple-negative breast cancer.
Wu X; Ding M; Lin J
Oncol Lett; 2020 Jan; 19(1):301-308. PubMed ID: 31897142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
